Creative Biolabs-Immuno-oncology

Anti-CCR7 (clone 1G2E1GG1G2E) SynExpress SV-YF-cJ-K Modified CD8+ T cells (CAT#: ITS-1224-CR354)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CCR7 (clone 1G2E1GG1G2E). We employs the pUC (SV40-YFP-c-Jun-KpnI) vector components and the SynExpress system of the miRNA Prime Editing/Negative feedback for a robust and sustained response against cancers.
Host
mouse
Target
CCR7
Clone
1G2E1GG1G2E
Species Reactivity
human
Cell Source
Modified CD8+ T cells
Sensor Gene
YFP
Promoter
SV40
Effector Gene
c-Jun
Insertion Sites
KpnI
Gene Modification
Prime Editing
Modification Domain
miRNA
Carrier Type
pUC
Transformation Accuracy
0.98
Cell Culture
Suspension Culture
Case Studies
Loading case studies...
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.